Komen Greater Fort Worth “Night of Hope” to Feature Expert in Young Women’s Breast Cancer Research and Treatment

Komen Greater Fort Worth “Night of Hope” to Feature Expert in Young Women’s Breast Cancer Research and Treatment

February 27, 2020
Contact Jean Tips, 214-240-1872 or Tracey Boyes, 214-960-9136
FOR IMMEDIATE RELEASE

Fort Worth, TX — Although the median age at breast cancer diagnosis is approximately 65, more than 14,000 women 40 years of age or younger are diagnosed each year in the United States. Because women in this younger age group represent a minority of the women diagnosed with breast cancer, far less is known about the disease in young women. Moreover, young women diagnosed with breast cancer face unique psychosocial stressors. How a young woman dates, how they dress, and how they cope with the threat to their life and even their fertility all are some of their unique quality of life issues.

Komen Scholar Ann Partridge, MD, MPH, Vice Chair of Medical Oncology, and founder and director of the Program for Young Women with Breast Cancer at Dana-Farber Cancer Institute in Boston, MA, will address the care and treatment of young women with breast cancer at Komen Greater Fort Worth’s Komen Scholar Educational Series: “A Night of Hope” on Thursday, March 5, 2020, from 5:30 p.m. to 7:30 p.m. at Moncrief Cancer Institute, 400 W. Magnolia Ave., Fort Worth. The free event will include a cocktail reception before the presentation.

Partridge said it was her best friend, who was diagnosed with breast cancer at age 30 while Partridge was 29, who helped her appreciate the unique toll breast cancer takes on young women.

How young is young for developing breast cancer? Partridge’s youngest patient in her clinic was 17, but she’s heard of patients as young as 13 developing breast cancer.

“The tragedies arise when a physician assumes that it’s nothing because the woman is too young to develop breast cancer and therefore doesn’t do a workup,” she said.

Komen Scholars are researchers from around the world selected to receive Komen funding. Partridge says she is deeply appreciative that Komen invests in work that pushes the boundaries other funding mechanisms deem too risky. Being a Komen Scholar not only provides a respected credential in the general research community, it also allows a researcher access to the rest of the Scholar scientific team.

“Komen funding is allowing us to go more deeply into the study of young women than ever before,” she said. “An example is our Young Women’s Breast Cancer Study, a cohort of 1,300 women that has been sustained and grown through Komen grants, allowing patient follow-up to extend beyond the original 10 years to 20.”

To RSVP, go to http://bit.ly/2VwJQCA.

Sponsors for the event are Moncrief Cancer Institute; Ann L. & Carol Green Rhodes Charitable Trust, Bank of America N.A. Trustee; Doris C. and Harry K. Werst Charitable Fund at the North Texas Community Foundation; Junior League of Fort Worth; UNT Health Science Center and Texas Health Resources.

ABOUT SUSAN G. KOMEN GREATER FORT WORTH:  The mission of Susan G. Komen Greater Fort Worth is to save lives by meeting the most critical needs in our communities and invest in breakthrough research to prevent and cure breast cancer. Seventy-five percent of all local donations fund screening and diagnostics, cancer treatment, education and support services for uninsured and underinsured women and men in the Komen Greater Fort Worth service area of Tarrant, Parker, Johnson, and Hood counties. The remaining 25 percent supports the national Komen Research Grants Program, which funds groundbreaking breast cancer research, meritorious awards and educational and scientific programs around the world. Find out more at komengreaterfortworth.org.